Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Exercise/Conversion of 9,450 INO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 9,450 | n/a |
| May 18, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,385 | n/a |
| Apr 1, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 4,292 | n/a |
| Mar 5, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 36,832 | n/a |
| Feb 27, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 5,010 | n/a |
| Jul 1, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,916 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 28,350 | n/a |
| May 16, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,385 | n/a |
| Feb 28, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 5,010 | n/a |
| Dec 19, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 5,708 | n/a |